Rituximab versus Cyclophosphamide in ANCA-Associated Renal Vasculitis
Rachel Jones(University of Cambridge), David Jayne(University of Cambridge)
Cited by 1,730
Related Papers
Avacopan for the Treatment of ANCA-Associated Vasculitis
|New England Journal of Medicine|2021|957
EULAR recommendations for the management of systemic lupus erythematosus: 2023 update
|Annals of the Rheumatic Diseases|2023|913
Treat-to-target in systemic lupus erythematosus: recommendations from an international task force
|Annals of the Rheumatic Diseases|2014|726
T-cell exhaustion, co-stimulation and clinical outcome in autoimmunity and infection
|Nature|2015|691
EULAR recommendations for the management of ANCA-associated vasculitis: 2022 update
|Annals of the Rheumatic Diseases|2023|635